Pig out: How an East Bay drug maker is betting on porcine-less disruption of cystic fibrosis

The company's drug offers promise to cystic fibrosis patients. But does it have enough cash to get it to the FDA finish line?

Source: bizjournals.com Health Care:Physician Practices headlines - March 7, 2018 Category: American Health Authors: Ron Leuty Source Type: news